What are the Challenges in Targeting Cathepsins for Cancer Treatment?
One of the main challenges in targeting cathepsins is their ubiquitous presence and involvement in normal physiological processes. Inhibiting cathepsins could potentially lead to unintended side effects, such as impaired immune response and tissue damage. Additionally, the redundancy and compensatory mechanisms among different proteases can complicate the effectiveness of cathepsin inhibitors.
